Ipca Laboratories

IPCALAB

₹ 1,312.95

₹ 28.70

2.23%

Ipca Laboratories
Market Sentiment

Timeline	Returns	Volume
Daily	-	-
Weekly	-1.85%	13,65,257
Monthly	-1.35%	66,26,317

Ipca Laboratories
Performance

DATA

CHART

Timeline	Daily	Weekly	Monthly
IPCALAB	-	-1.85%	-1.35%
Index	-	-1.46%	-2.67%
Peer Avg.	-	-3.10%	-0.58%

*Avg of index constituents

Ipca Laboratories
Fundamentals

DATA

CHART

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
IPCALAB	30.68	4.89	18.91	17.41	19.96	0.46
Index	36.20	6.77	17.25	17.89	19.69	1.20
Peer Avg.	40.04	4.96	12.35	14.74	18.51	0.87

*Avg of index constituents

Ipca Laboratories
Key Metrics

DATA

CHART

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	6.19%	-22.18%	17.41	19.96
FY '20-21	17.35%	81.38%	27.36	30.73
FY '19-20	21.81%	40.56%	18.67	20.38

Ipca Laboratories
Shareholding Pattern

Promoters : 46.29%

FII : 11.02%

DII : 32.94%

Public : 9.75%

Others : 0%

Ipca Laboratories
Profit & Loss

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	5,581.70	4,357.43	1,341.09	890.95
FY '20-21	5,254.52	3,788.80	1,594.62	1,144.81
FY '19-20	4,478.43	3,584.02	979.74	631.91

All values are in crores

Ipca Laboratories
Peer Comparison

DATA

CHART

Metrics	Sales	Expenditure	EBITDA	PAT
IPCALAB	5,581.70	4,357.43	1,341.09	890.95
POONAWALLA	1,770.30	1,225.51	1,102.12	333.55
CRISIL	0	0	0	0

All values are in crores

Ipca Laboratories
Similar Stocks

Glaxosmithkline Pharmaceuticals

GLAXO

₹ 1,972.30

- ₹ 3.60

-0.18%

Ipca Laboratories Share Price

Ipca Laboratories Limited is an Indian pharmaceutical company. The company manufactures and markets more than 350 dosage forms and approximately 80 active ingredients (APIs) covering various therapeutic segments. It offers APIs such as atenolol, chloroquine phosphate, chlorthalidone, furosemide, hydroxychloroquine sulfate, losartan, metoprolol succinate, metoprolol tartrate, pyrantel salts and propranolol. The company offers brands such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The company's products are sold in more than 100 countries around the world. The company has 18 manufacturing facilities in India that manufacture APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc., Ipca Laboratories (U.K.) Ltd and Tonira Exports Limited.

Ipca Laboratories FAQs

How to Buy Ipca Laboratories Share?

To purchase Ipca Laboratories shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Ipca Laboratories (ticker symbol: ipcalab) on the trading platform provided by your broker and purchase the shares.

What's Ipca Laboratories share price today?

The stock price of Ipca Laboratories as of 10 May 2024 is ₹1,312.95

What is the Market Cap of Ipca Laboratories?

Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Ipca Laboratories (ticker symbol: ipcalab) has a market capitalisation of approximately ₹2,20,77,34,10,503.60

What is the PE and PB ratio of Ipca Laboratories?

Ipca Laboratories Ltd's price-to-book ratio as of 10 May 2024 is 4.888032, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 30.680992, indicating the market values the company at around ₹30.68 for every ₹1 of earnings

What is the 52 Week High and Low of Ipca Laboratories Share?

Ipca Laboratories Ltd (ipcalab) hit its 52-week high at ₹1,374.60, and its 52-week low at { ₹669.80}.